Annual FCF
-$171.00 M
-$54.13 M-46.32%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual free cash flow is currently -$171.00 million, with the most recent change of -$54.13 million (-46.32%) on 31 December 2023. During the last 3 years, it has fallen by -$108.78 million (-174.85%). CRNX annual FCF is now -2922.18% below its all-time high of -$5.66 million, reached on 31 December 2016.CRNX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$63.35 M
-$16.78 M-36.03%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly free cash flow is currently -$63.35 million, with the most recent change of -$16.78 million (-36.03%) on 30 September 2024. Over the past year, it has dropped by -$18.51 million (-41.29%). CRNX quarterly FCF is now -2735.77% below its all-time high of -$2.23 million, reached on 30 June 2017.CRNX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$203.56 M
-$18.51 M-10.00%
30 September 2024
Summary:
Crinetics Pharmaceuticals TTM free cash flow is currently -$203.56 million, with the most recent change of -$18.51 million (-10.00%) on 30 September 2024. Over the past year, it has dropped by -$36.53 million (-21.87%). CRNX TTM FCF is now -8576.94% below its all-time high of -$2.35 million, reached on 31 March 2017.CRNX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.3% | -41.3% | -21.9% |
| 3 y3 years | -174.8% | -145.4% | -148.1% |
| 5 y5 years | -733.4% | -365.6% | -412.9% |
CRNX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -174.8% | at low | -364.8% | at low | -148.1% | at low |
| 5 y | 5 years | -733.4% | at low | -415.5% | at low | -412.9% | at low |
| alltime | all time | -2922.2% | at low | -2735.8% | at low | -8576.9% | at low |
Crinetics Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$63.35 M(+36.0%) | -$203.56 M(+10.0%) |
| June 2024 | - | -$46.57 M(-14.1%) | -$185.05 M(+0.3%) |
| Mar 2024 | - | -$54.19 M(+37.4%) | -$184.45 M(+7.9%) |
| Dec 2023 | -$171.00 M(+46.3%) | -$39.45 M(-12.0%) | -$171.00 M(+2.4%) |
| Sept 2023 | - | -$44.84 M(-2.5%) | -$167.03 M(+3.5%) |
| June 2023 | - | -$45.97 M(+12.9%) | -$161.35 M(+12.1%) |
| Mar 2023 | - | -$40.73 M(+14.8%) | -$143.97 M(+23.2%) |
| Dec 2022 | -$116.86 M(+31.3%) | -$35.48 M(-9.4%) | -$116.86 M(+12.0%) |
| Sept 2022 | - | -$39.16 M(+37.0%) | -$104.30 M(+14.7%) |
| June 2022 | - | -$28.59 M(+109.8%) | -$90.95 M(+10.3%) |
| Mar 2022 | - | -$13.63 M(-40.5%) | -$82.47 M(-7.4%) |
| Dec 2021 | -$89.02 M(+43.1%) | -$22.92 M(-11.2%) | -$89.02 M(+8.5%) |
| Sept 2021 | - | -$25.81 M(+28.4%) | -$82.06 M(+10.4%) |
| June 2021 | - | -$20.11 M(-0.4%) | -$74.35 M(+6.1%) |
| Mar 2021 | - | -$20.18 M(+26.5%) | -$70.11 M(+12.7%) |
| Dec 2020 | -$62.21 M | -$15.96 M(-11.9%) | -$62.21 M(+4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$18.10 M(+14.1%) | -$59.73 M(+8.1%) |
| June 2020 | - | -$15.87 M(+29.1%) | -$55.24 M(+6.2%) |
| Mar 2020 | - | -$12.29 M(-8.8%) | -$52.00 M(+10.9%) |
| Dec 2019 | -$46.87 M(+128.4%) | -$13.47 M(-1.0%) | -$46.87 M(+18.1%) |
| Sept 2019 | - | -$13.61 M(+7.8%) | -$39.69 M(+23.9%) |
| June 2019 | - | -$12.62 M(+76.1%) | -$32.03 M(+32.2%) |
| Mar 2019 | - | -$7.17 M(+13.9%) | -$24.22 M(+18.0%) |
| Dec 2018 | -$20.52 M(+109.7%) | -$6.29 M(+5.8%) | -$20.52 M(+20.9%) |
| Sept 2018 | - | -$5.94 M(+23.3%) | -$16.97 M(+25.8%) |
| June 2018 | - | -$4.82 M(+39.1%) | -$13.49 M(+23.7%) |
| Mar 2018 | - | -$3.46 M(+26.3%) | -$10.90 M(+11.4%) |
| Dec 2017 | -$9.78 M(+72.9%) | -$2.74 M(+11.4%) | -$9.78 M(+38.9%) |
| Sept 2017 | - | -$2.46 M(+10.2%) | -$7.04 M(+53.7%) |
| June 2017 | - | -$2.23 M(-4.8%) | -$4.58 M(+95.2%) |
| Mar 2017 | - | -$2.35 M | -$2.35 M |
| Dec 2016 | -$5.66 M | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual FCF year-on-year change?
- What is Crinetics Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly FCF year-on-year change?
- What is Crinetics Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM FCF year-on-year change?
What is Crinetics Pharmaceuticals annual free cash flow?
The current annual FCF of CRNX is -$171.00 M
What is the all time high annual FCF for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual free cash flow is -$5.66 M
What is Crinetics Pharmaceuticals annual FCF year-on-year change?
Over the past year, CRNX annual free cash flow has changed by -$54.13 M (-46.32%)
What is Crinetics Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of CRNX is -$63.35 M
What is the all time high quarterly FCF for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly free cash flow is -$2.23 M
What is Crinetics Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, CRNX quarterly free cash flow has changed by -$18.51 M (-41.29%)
What is Crinetics Pharmaceuticals TTM free cash flow?
The current TTM FCF of CRNX is -$203.56 M
What is the all time high TTM FCF for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM free cash flow is -$2.35 M
What is Crinetics Pharmaceuticals TTM FCF year-on-year change?
Over the past year, CRNX TTM free cash flow has changed by -$36.53 M (-21.87%)